Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012)
Vertex Pharmaceuticals (VRTX) posted Change in Taxes of -$3.2 million for Q4 2012, down 185.99% on a QoQ basis from $3.7 million in Q3 2012, and down 236.03% year-over-year from $2.3 million in Q1 2012.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012) Analysis & Trends
Vertex Pharmaceuticals has reported Change in Taxes for 2 years, with the latest figure at -$3.2 million in Q4 2012.
- On a quarterly basis, Change in Taxes fell 236.03% year-over-year to -$3.2 million in Q4 2012; TTM through Dec 2012 was -$11.4 million, a N/A change from a year earlier, with the FY2012 full-year figure at -$11.4 million, down 194.08% from the prior year.
- Change in Taxes was -$3.2 million for Q4 2012 at Vertex Pharmaceuticals, down from $3.7 million in the prior quarter.
- The five-year high for Change in Taxes was $3.7 million in Q3 2012, with the low at -$11.9 million in Q1 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | -131.00 Mn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 171.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 13.80 Mn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -10.18 Mn |
| 10 | Insmed | 28.06 Bn | 26.90 Bn | 358.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | -3.16 Mn |
| Sep 30, 2012 | 3.67 Mn |
| Mar 31, 2012 | -11.87 Mn |
| Dec 31, 2011 | 2.32 Mn |
| Sep 30, 2011 | -5.46 Mn |